Oligopeptides that specifically inhibit membrane fusion by paramyxoviruses: studies on the site of action.
Previous studies from this laboratory showed that oligopeptides with amino acid sequences similar to the sequence of the N-terminal region of the F1 polypeptide of paramyxoviruses inhibited the membrane fusing activity of the F protein, and thereby inhibited virus infectivity at the level of penetration and virus-induced cell fusion and hemolysis. The site of action of these oligopeptide inhibitors has been investigated. Radioactively labeled oligopeptides were found to bind to cells, but not to virus. Pretreatment of cells, but not virus, at 4 degrees with oligopeptides inhibited the initiation of infection and hemolysis induced by measles virus. The binding of the oligopeptides to cells was reversible at 25 or 37 degrees. Oligopeptides were synthesized with a chloromethylketone group to enable them to bind irreversibly, or with an azido group to permit them to be cross-linked in situ by photoactivation. The results with these derivatized oligopeptides, which retained their inhibitory activity, confirmed that they bind to, and express their inhibitory activity on, cells and not virus. The results suggest that the oligopeptides react with receptor sites on the cell membrane and inhibit membrane-fusing activity by competing with the F1 polypeptide for such sites. A Scatchard analysis of the binding of an oligopeptide to CV-1 cells revealed that it bound with a dissociation constant of 1.2 X 10(-7) M and that there were approximately 3.0 X 10(6) binding sites per cell.
D000818:Animals; D001665:Binding Sites / Q000187:drug effects; D002459:Cell Fusion / Q000187:drug effects; D002462:Cell Membrane / Q000187:drug effects; D006461:Hemolysis / Q000187:drug effects; D008459:Measles virus / Q000187:drug effects; D009842:Oligopeptides / Q000378:metabolism / Q000494:pharmacology*; D010252:Paramyxoviridae / Q000187:drug effects*; D013329:Structure-Activity Relationship; D013696:Temperature; D014759:Viral Envelope Proteins / Q000037:antagonists & inhibitors; D014760:Viral Fusion Proteins; D014776:Virus Cultivation
D009842:Oligopeptides; D014759:Viral Envelope Proteins; D014760:Viral Fusion Proteins